Received Mar 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
stroke; cant walk or speak; cant walk or speak; couldn't write; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Patient was was perfectly fit before 2021. Patient was retired with 21 years. Vaccination history included: Covid- 19 vaccine (Dose 1 single), for Covid-19 immunization. The following information was reported: CEREBROVASCULAR ACCIDENT (hospitalization), outcome "unknown", described as "stroke"; GAIT INABILITY (disability), SPEECH DISORDER (disability), all with latency 1 week after the suspect product(s) administration, outcome "unknown" and all described as "cant walk or speak"; DYSGRAPHIA (non-serious), outcome "recovering", described as "couldn't write". The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.